Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Aldape

Showing results (11-20 of 345) with videos related to

Pageof 35
Sort By:
Neuro-Oncology|October 19, 2014
CMV and glioma--are we there yet?Jason T Huse, Kenneth Aldape
Handbook of Clinical Neurology|January 11, 2012
Molecular biology of brain tumorsJing Li, Erik Sulman, Kenneth Aldape
Neurosurgery Clinics of North America|March 30, 2021
Morphologic and Molecular Aspects of GlioblastomasOsorio Lopes Abath Neto, Kenneth Aldape
Neuro-Oncology|May 18, 2019
Needle in a haystack: identifying drivers of malignant transformation in neurofibromasSuganth Suppiah, Kenneth Aldape, Gelareh Zadeh
Cancer Discovery|July 13, 2013
Not expecting the unexpected: diacylglycerol kinase alpha as a cancer targetKrishna P L Bhat, Kenneth Aldape
Neuro-Oncology|November 16, 2017
IDH mutation testing in gliomas-where do we draw the line?Farshad Nassiri, Gelareh Zadeh, Kenneth Aldape
Neuro-Oncology|November 2, 2021
DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncologyDrew Pratt, Felix Sahm, Kenneth Aldape
Acta Neuropathologica Communications|September 9, 2021
Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumorsOmkar Singh, Drew Pratt, Kenneth Aldape
Neuro-Oncology|March 30, 2018
The multiforme of glioblastomaFarshad Nassiri, Kenneth Aldape, Gelareh Zadeh
Archives of Pathology & Laboratory Medicine|February 8, 2007
Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendrogliomaKenneth Aldape, Peter C Burger, Arie Perry
Pageof 35

Showing results (11-20 of 345) with videos related to

Sort By:
Pageof 35
Neuro-Oncology|October 19, 2014
CMV and glioma--are we there yet?Jason T Huse, Kenneth Aldape
Handbook of Clinical Neurology|January 11, 2012
Molecular biology of brain tumorsJing Li, Erik Sulman, Kenneth Aldape
Neurosurgery Clinics of North America|March 30, 2021
Morphologic and Molecular Aspects of GlioblastomasOsorio Lopes Abath Neto, Kenneth Aldape
Neuro-Oncology|May 18, 2019
Needle in a haystack: identifying drivers of malignant transformation in neurofibromasSuganth Suppiah, Kenneth Aldape, Gelareh Zadeh
Cancer Discovery|July 13, 2013
Not expecting the unexpected: diacylglycerol kinase alpha as a cancer targetKrishna P L Bhat, Kenneth Aldape
Neuro-Oncology|November 16, 2017
IDH mutation testing in gliomas-where do we draw the line?Farshad Nassiri, Gelareh Zadeh, Kenneth Aldape
Neuro-Oncology|November 2, 2021
DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncologyDrew Pratt, Felix Sahm, Kenneth Aldape
Acta Neuropathologica Communications|September 9, 2021
Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumorsOmkar Singh, Drew Pratt, Kenneth Aldape
Neuro-Oncology|March 30, 2018
The multiforme of glioblastomaFarshad Nassiri, Kenneth Aldape, Gelareh Zadeh
Archives of Pathology & Laboratory Medicine|February 8, 2007
Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendrogliomaKenneth Aldape, Peter C Burger, Arie Perry
Pageof 35